Search
SF Healthcare Week: Roivant CEO Matt Gline describes the backstory behind this week's viral "Toy Story" video, and discusses the pivotal year the company had last year and what is ahead
He shares updates on Brepocitinib, IMVT-1402, and the company's LNP lawsuit against Moderna.
Jan 14
SF Healthcare Week: Roivant CEO Matt Gline provides an update on the 'vant ecosystem
He discusses key data in the year ahead including from Immunovant and Priovant. Plus, an update on the lawsuits regarding covid vaccine...
Jan 13, 2025
Health 2035 Summit: Roivant CEO Matt Gline on why he believes this is a good time to be hunting for assets on the shelves of big pharma, and upcoming catalysts
He describes why this may be a good time to asset hunt, but also why Roivant has been conservative with its cash. Plus upcoming catalysts...
Aug 27, 2024
Roivant's Matt Gline on the success of Telavant, Immunovant's FcRn program, and his expectations for the company's cash usage
Matt Gline reflects on learnings from the Telavant success, and why he thinks Immunovant's FcRn might be best in class.
Jan 22, 2024
.png){kind=logo}
